总统拜登(Biden)提出的覆盖肥胖症治疗的建议可以提升诺沃·诺迪斯克(Novo Nordisk)和伊莱·莉莉(Eli Lilly)的股份。 President Biden's proposal to cover obesity treatments could boost Novo Nordisk and Eli Lilly shares.

Novo Nordisk和Eli Lilly的份额在拜登总统提议将肥胖症治疗纳入医疗保险范围后有所上升。 Shares of Novo Nordisk and Eli Lilly rose after President Biden proposed including obesity treatments under healthcare coverage. 此举可以增加肥胖症药物和疗法的获得机会,使这些产品被用于肥胖症治疗的制药公司受益。 This move could increase access to medications and therapies for obesity, benefiting these pharmaceutical companies whose products are used in obesity treatment.